Patent pool inks major COVID-19 deal with Japanese company

The Medicines Patent Pool (MPP) and Japanese pharma company, Shionogi, have entered a licensing agreement centring on an oral antiviral treatment to treat COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals

8 January 2026 An annual, first-of-its-kind project aims to highlight the world’s leading in-house intellectual property counsel—and we need your help.

Careers

Arnold & Porter loses another regulatory partner to growing rival

7 January 2026 A Brussels-based partner, specialising in pharmaceuticals and biologics, jumps ship as a competitor firm continues to build out its EU healthcare regulatory bench.

Americas

Merchant & Gould hires 13 attorneys to open new Boston office

6 January 2026 The new recruits from a boutique Boston firm enables Merchant to expand and strengthen its tech and life sciences offering in the innovation hub.

More features

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals

Arnold & Porter loses another regulatory partner to growing rival

CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’

Merchant & Gould hires 13 attorneys to open new Boston office

Novo Nordisk secures China win ahead of key patent expiration

Edwards v Meril: Inside the UPC’s landmark medtech showdown

Bird & Bird targets Nordic life sciences growth with regulatory hire

PTAB year in review: A shifting landscape and outlook for 2026

Patent pool inks major COVID-19 deal with Japanese company

More on this story

Editor's picks

Editor's picks

More features